HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yusuke Suenaga Selected Research

N-Myc Proto-Oncogene Protein

1/2020Erratum: Combining peptide TNIIIA2 with all-trans retinoic acid accelerates N-Myc protein degradation and neuronal differentiation in MYCN-amplified neuroblastoma cells.
8/2019Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins.
1/2019Combining peptide TNIIIA2 with all-trans retinoic acid accelerates N-Myc protein degradation and neuronal differentiation in MYCN-amplified neuroblastoma cells.
1/2014NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas.
12/2009Positive auto-regulation of MYCN in human neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yusuke Suenaga Research Topics

Disease

12Neoplasms (Cancer)
02/2022 - 09/2008
12Neuroblastoma
02/2022 - 11/2008
2Carcinogenesis
10/2019 - 10/2018
1Urinary Bladder Neoplasms (Bladder Cancer)
08/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
08/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2018
1Adenocarcinoma
10/2018
1Glioblastoma (Glioblastoma Multiforme)
01/2013
1Lung Neoplasms (Lung Cancer)
11/2008

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
01/2021 - 09/2012
5N-Myc Proto-Oncogene ProteinIBA
01/2020 - 12/2009
4Messenger RNA (mRNA)IBA
02/2022 - 12/2009
4Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020 - 12/2009
3Pharmaceutical PreparationsIBA
01/2021 - 12/2009
2Peptides (Polypeptides)IBA
01/2020 - 01/2019
2Oncogene Proteins (Oncogene Protein)IBA
08/2019 - 01/2019
2Biological ProductsIBA
12/2013 - 09/2012
2ElementsIBA
12/2009 - 09/2008
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
02/2022
1CateninsIBA
08/2020
1PF 00477736IBA
01/2020
1Protein Isoforms (Isoforms)IBA
10/2019
1SolutionsIBA
01/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1TenascinIBA
01/2019
1RNA (Ribonucleic Acid)IBA
10/2018
1MicroRNAs (MicroRNA)IBA
10/2018
1CalpainIBA
06/2015
1dactolisibIBA
01/2014
1Untranslated RNA (Noncoding RNA)IBA
01/2014
1Temozolomide (Temodar)FDA LinkGeneric
01/2013
1Leucine (L-Leucine)FDA Link
09/2012
1Epidermal Growth Factor (EGF)IBA
09/2012
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1CarbonIBA
12/2009
1Glucose (Dextrose)FDA LinkGeneric
12/2009
1AMP-Activated Protein KinasesIBA
12/2009
1Carrier Proteins (Binding Protein)IBA
12/2009
1Immunoglobulins (Immunoglobulin)IBA
11/2008
1DNA (Deoxyribonucleic Acid)IBA
11/2008
1Cell Adhesion Molecule-1IBA
11/2008
1Small Interfering RNA (siRNA)IBA
09/2008

Therapy/Procedure

2Therapeutics
01/2021 - 01/2019
2Drug Therapy (Chemotherapy)
08/2019 - 01/2019